Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
- PMID: 20117458
- DOI: 10.1016/j.jacc.2009.08.060
Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
Comment on
-
Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.J Am Coll Cardiol. 2010 Feb 2;55(5):441-50. doi: 10.1016/j.jacc.2009.07.069. J Am Coll Cardiol. 2010. PMID: 20117457 Free PMC article.
Similar articles
-
N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Expert Rev Cardiovasc Ther. 2005 May;3(3):487-96. doi: 10.1586/14779072.3.3.487. Expert Rev Cardiovasc Ther. 2005. PMID: 15889976 Review.
-
Natriuretic peptides in heart failure: their role in daily practice.Cardiol J. 2009;16(1):1-3. Cardiol J. 2009. PMID: 19130409 No abstract available.
-
B-type natriuretic peptide as a marker of heart failure: Not so specific after all?Crit Care Med. 2006 Aug;34(8):2249. doi: 10.1097/01.CCM.0000229675.78883.E9. Crit Care Med. 2006. PMID: 16883197 No abstract available.
-
Advances in heart failure: natriuretic peptide testing.Panminerva Med. 2008 Jun;50(2):139-51. Panminerva Med. 2008. PMID: 18607337 Review.
-
Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029. Am J Cardiol. 2009. PMID: 19539088
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical